Triazolam

Chemical formula: C₁₇H₁₂Cl₂N₄  Molecular mass: 343.21 g/mol  PubChem compound: 5556

Therapeutic indications

Triazolam is indicated for:

Insomnia

Population group: only adults (18 years old or older)

Benzodiazepines are only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Triazolam is contraindicated in the following cases:

Myasthenia gravis

Myasthenia gravis

Severe respiratory insufficiency

Respiratory insufficiency

Sleep apnoea syndrome

Sleep apnea

Severe hepatic insufficiency

Hepatic failure stage IV

Hypersensitivity to benzodiazepines

Benzodiazepine allergy

Strong CYP 3A inhibitors

at least one of
Strong CYP3A4 inhibitors
Cytochrome P-450 CYP3A5 strong inhibitors

HIV protease inhibitors

Protease inhibitors

Efavirenz

Efavirenz

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: HALCION Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈